Advertisement
UK markets close in 22 minutes
  • FTSE 100

    7,876.44
    +28.45 (+0.36%)
     
  • FTSE 250

    19,408.90
    +68.76 (+0.36%)
     
  • AIM

    745.11
    +1.99 (+0.27%)
     
  • GBP/EUR

    1.1679
    +0.0012 (+0.11%)
     
  • GBP/USD

    1.2448
    -0.0008 (-0.06%)
     
  • Bitcoin GBP

    51,305.05
    +2,250.32 (+4.59%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,051.00
    +28.79 (+0.57%)
     
  • DOW

    38,063.99
    +310.68 (+0.82%)
     
  • CRUDE OIL

    82.35
    -0.34 (-0.41%)
     
  • GOLD FUTURES

    2,396.90
    +8.50 (+0.36%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,836.82
    +66.80 (+0.38%)
     
  • CAC 40

    8,024.70
    +43.19 (+0.54%)
     

Why Shares of Bausch Health Soared Wednesday

Why Shares of Bausch Health Soared Wednesday

Shares of Bausch Health (NYSE: BHC) were up more than 27% late Wednesday afternoon because the company announced it had received a favorable court ruling affecting one of its leading therapies. The healthcare company announced that the U.S. District Court of Delaware had ruled in its favor in a lawsuit by Bausch wholly owned subsidiary Salix Pharmaceuticals against Norwich Pharmaceuticals.